Hims & Hers Health - Class A Stock News

Hims & Hers Health Inc (NYSE: HIMS) entered an on-demand delivery partnership with Uber Technologies Inc (NYSE: UBER) to bring its personal care products to customers through the Uber Eats app. T

Renaissance Technologies LLC bought a new stake in Hims & Hers Health, Inc. (NYSE:HIMS) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 17,500 shares of the companys stock, valued at approximately $191,000. Other institutional investors have also recently bought and sold shares []

In the last trading session, 4.44 million shares of the Hims & Hers Health Inc. (NYSE:HIMS) were traded. Most recently the companys share price was $7.15, and it changed around -$0.16 or -2.19% from the last close, which brings the market valuation of the company to $1.42B. HIMS currently trades at a discount to its Hims & Hers Health Inc. (NYSE: HIMS) Could Have Exceptional Returns? Read More »

Berman Capital Advisors LLC bought a new position in shares of Hims & Hers Health, Inc. (NYSE:HIMS) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 22,401 shares of the companys stock, valued at approximately $168,000. Other hedge funds have also recently []

Related Stocks: HOOD , HIMS ,

The shares of Hims & Hers Health Inc (NYSE: HIMS) have received a price target of $12 from Piper Sandler. These are the details.

In the last trading session, 5.73 million Hims & Hers Health Inc. (NYSE:HIMS) shares changed hands as the companys beta touched 0. With the companys per share price at $8.17 changed hands at $0.77 or 10.41% during last session, the market valuation stood at $1.66B. HIMSs last price was a discount, traded about -210.89% off Hims & Hers Health Inc. (NYSE: HIMS) Gain 10.41%, Marking A Loss For Bears. Read More »

Hims & Hers: Eventually The Ugly Duckling Becomes A Beautiful Swan

Hims & Hers Health, Inc. (NYSE:HIMS) has earned a consensus recommendation of Buy from the ten brokerages that are currently covering the company, Marketbeat reports. Five equities research analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average twelve-month price target among brokers that []

Hims & Hers Health, Inc. (HIMS) CEO Andrew Dudum on Q3 2021 Results - Earnings Call Transcript

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experienc

Investors are skeptical of Hims & Hers, pushing the stock back toward 52-week lows during September's sell-off. But are they right?

Wellness and telehealth company Hims & Hers Health Inc. HIMS, +2.03% said Monday that its haircare products will now be available at 280 Vitamin Shoppe locations and on the retailer's website. Vitamin

Hims & Hers Health Inc (NYSE: HIMS) has partnered with The Vitamin Shoppe , a subsidiary of Franchise Group Inc (NASDAQ: FRG), to make its products available on the latter's platform. The financi